« Back to Record
Citation APA

Viscoli, C., Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Crokaert, F., Glauser, M., Calandra, T., Akan, H., Marchetti, O., Vandercam, B., Aoun, M., Skoutelis, A., Drgona, L., Schaffner, A., Pichna, P., Korten, V., Akova, M., Petrikkos, G., Powles, R., Caballero, D., Hatziyanni, M., Van Lint, M., Garaventa, A., Shapiro, M., Cavalli, F., Engelhard, D., & Jacobs, F. (2006). Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clinical microbiology and infection, 12(3), 212-216. doi:10.1111/j.1469-0691.2005.01297.x


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/86058

Viscoli, C., Cometta, A., Kern, W. V., De Bock, R., Paesmans, M., Crokaert, F., Glauser, M., Calandra, T., Akan, H., Marchetti, O., Vandercam, B., Aoun, M., Skoutelis, A., Drgona, L., Schaffner, A., Pichna, P., Korten, V., Akova, M., Petrikkos, G., Powles, R., Caballero, D., Hatziyanni, M., Van Lint, M., Garaventa, A., Shapiro, M., Cavalli, F., Engelhard, D., & Jacobs, F. (2006). Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients. Clinical microbiology and infection, 12(3), 212-216. doi:10.1111/j.1469-0691.2005.01297.x